Skip to Main Content

President-Elect Trump Proposes Dr. Jay Bhattacharya to Lead NIH

Dec. 3, 2024
President-elect Trump announced his intent for Jay Bhattacharya, MD, PhD, to serve as director of the National Institutes of Health (NIH). Dr. Bhattacharya is a professor of health policy at Stanford University’s Freeman Spogli Institute and Stanford School of Medicine. A Stanford-educated physician and economist, he was critical of the federal government’s response to the COVID-19 pandemic.

The announcement was posted on the president-elect’s social media platform, Truth Social, writing Bhattacharya would work in coordination with Robert F. Kennedy Jr. to “direct the Nation’s Medical Research, and to make important discoveries that will improve…health, and save lives.”

The nomination must go through the U.S. Senate for approval before it is finalized. If confirmed, Dr. Bhattacharya will oversee a $47 billion budget that oversees clinical trials, efforts to develop drugs and issues research grants, among other tasks.

For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.

Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more

  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more

  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more